DaVita (NYSE:DVA) Hits New 1-Year High After Better-Than-Expected Earnings

Shares of DaVita Inc. (NYSE:DVA) hit a new 52-week high on Thursday following a better than expected earnings announcement. The stock traded as high as $142.29 and last traded at $141.17, with a volume of 90917 shares traded. The stock had previously closed at $139.75.

The company reported $2.38 earnings per share for the quarter, topping the consensus estimate of $1.95 by $0.43. DaVita had a return on equity of 66.59% and a net margin of 6.61%. The company had revenue of $3.07 billion during the quarter, compared to the consensus estimate of $3.03 billion. During the same quarter in the prior year, the company earned $1.58 EPS. The firm’s quarterly revenue was up 6.9% compared to the same quarter last year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on DVA shares. TheStreet raised shares of DaVita from a “c+” rating to a “b-” rating in a report on Wednesday, February 7th. UBS Group upped their price target on shares of DaVita from $113.00 to $134.00 and gave the stock a “buy” rating in a report on Wednesday, February 14th. StockNews.com upgraded DaVita from a “buy” rating to a “strong-buy” rating in a research report on Thursday, April 25th. Barclays initiated coverage on DaVita in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $133.00 price target on the stock. Finally, Truist Financial boosted their price objective on DaVita from $130.00 to $135.00 and gave the stock a “hold” rating in a report on Tuesday, February 20th. Two equities research analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $118.50.

Insider Buying and Selling

In related news, CEO Javier Rodriguez sold 67,603 shares of DaVita stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the sale, the chief executive officer now directly owns 488,697 shares in the company, valued at $61,629,578.67. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CEO Javier Rodriguez sold 67,603 shares of the company’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $126.11, for a total value of $8,525,414.33. Following the transaction, the chief executive officer now owns 488,697 shares in the company, valued at approximately $61,629,578.67. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Michael David Staffieri sold 29,488 shares of the stock in a transaction that occurred on Wednesday, February 21st. The shares were sold at an average price of $119.81, for a total transaction of $3,532,957.28. Following the sale, the chief operating officer now owns 37,687 shares in the company, valued at approximately $4,515,279.47. The disclosure for this sale can be found here. Insiders sold a total of 134,540 shares of company stock valued at $16,551,071 over the last three months. Corporate insiders own 1.40% of the company’s stock.

Institutional Trading of DaVita

A number of institutional investors have recently made changes to their positions in DVA. Newbridge Financial Services Group Inc. bought a new position in DaVita during the fourth quarter valued at approximately $30,000. Hanseatic Management Services Inc. bought a new position in shares of DaVita during the 3rd quarter valued at $36,000. Principal Securities Inc. purchased a new position in shares of DaVita in the 4th quarter worth $37,000. GAMMA Investing LLC bought a new stake in shares of DaVita in the fourth quarter worth $60,000. Finally, FinTrust Capital Advisors LLC lifted its holdings in DaVita by 242.3% in the third quarter. FinTrust Capital Advisors LLC now owns 712 shares of the company’s stock valued at $67,000 after acquiring an additional 504 shares during the period. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Price Performance

The firm has a 50-day simple moving average of $133.52 and a 200-day simple moving average of $112.17. The firm has a market capitalization of $11.79 billion, a PE ratio of 15.28, a PEG ratio of 1.27 and a beta of 1.04. The company has a debt-to-equity ratio of 6.65, a current ratio of 1.19 and a quick ratio of 1.13.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.